Dianthus Therapeutics
DNTH
DNTH
74 hedge funds and large institutions have $437M invested in Dianthus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
19
Reduced
18
Closed
10
Calls
$3K
Puts
$2K
Net Calls
+$1K
Net Calls Change
+$1K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AA
76
ALPS Advisors
Denver,
Colorado
| – | -$793K | -4,833 | Closed |
|
|
BCM
77
BlueCrest Capital Management
St Helier,
Jersey
| – | -$410K | -2,500 | Closed |
|
|
VEA
78
Virtus ETF Advisers
New York
| – | -$181K | -1,100 | Closed |
|
|
AG
79
Algert Global
San Francisco,
California
| – | -$129K | -784 | Closed |
|
80
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$109K | -664 | Closed |
|
|
OAM
81
Oxford Asset Management
Oxford,
United Kingdom
| – | -$103K | -630 | Closed |
|
82
UBS Group
Zurich,
Switzerland
| – | -$92K | -562 | Closed |
|
83
Victory Capital Management
San Antonio,
Texas
| – | -$31K | -187 | Closed |
|
|
MAM
84
Meeder Asset Management
Dublin,
Ohio
| – | -$1K | -8 | Closed |
|